HSCS

Announcements

Nothing here yet

Daily updates

• HeartSciences received FDA 510(k) clearance for MyoVista wavECG as a standard 12-lead resting electrocardiograph.Oct 7, 2026

FDA designations

Nothing here yet

News

• HeartSciences received a European patent for ECG-based assessment of diastolic function, expanding its patent portfolioJun 11, 2026
• HeartSciences announces FDA 510(k) submission for MyoVista® wavECG™ deviceDec 15, 2025
• HeartSciences receives FDA Breakthrough Device Designation for AI-ECG algorithm MyoVista Insights to detect aortic stenosisJun 5, 2025
• HeartSciences awarded foundational U.S. patent for ECG-based heart function assessment, expanding its IP portfolioJun 3, 2025